ANN ARBOR (WWJ) – Truven Health Analytics announced that it has closed its offer to exchange up to $327,150,000 aggregate principal amount of its 10.625% Senior Notes, Series B, due 2020, which have been registered under the United States Securities Act of 1933, for its outstanding 10.625% Senior Notes, Series A, due 2020 that were originally issued on June 6, 2012, in a transaction exempt from registration under the Securities Act and state securities laws.
The Exchange Offer expired at 5 p.m. Eastern time on July 26. The company has accepted for exchange all $327,150,000 aggregate principal amount of the Old Notes tendered. The closing of the Exchange Offer was July 31.
The Exchange Offer was made to satisfy the company’s obligations under a registration rights agreement dated June 6 entered into in connection with the original issuance of the Old Notes, and did not represent a new financing transaction. Pursuant to the Registration Rights Agreement, the company was required to file the Exchange Offer registration statement by March 3. As a result of not filing the Exchange Offer registration statement by March 3, the company was required to pay additional interest on the Old Notes from March 4, until completion of the exchange offer. With the completion of the exchange offer and the cancellation of all of the outstanding old notes, the interest rate on the new exchange notes will revert to 10.625% as of Aug. 1.
The CUSIP number for the Exchange Notes is 89845XAA7.
Truven Health Analytics delivers unbiased information, analytic tools, benchmarks and services to the healthcare industry. Hospitals, government agencies, employers, health plans, clinicians, and pharmaceutical companies have relied on its solutions for over 30 years.
For more information, please visit http://www.truvenhealth.com.